![Ronald Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Cooper
Algemeen Directeur bij
ENGENE THERAPEUTICS INC.
Vermogen: 18 500 $ op 31-05-2026
Profiel
Ronald Harold Wilfred Cooper is President, Chief Executive Officer & Director at enGene Therapeutics, Inc. since 2024.
Mr. Cooper is Chairman at C4 Therapeutics, Inc. since 2024.
Mr. Cooper was President, Chief Executive Officer & Director at Albireo AB. Mr. Cooper was President, Chief Executive Officer & Director at Albireo Pharma, Inc. from 2016 to 2023.
Mr. Cooper was Independent Director at Genocea Biosciences, Inc. from 2016 to 2021.
Mr. Cooper was Director at Albireo Ltd. from 2016 to 2021.
Mr. Cooper was Independent Director at Generation Bio Co. from 2021 to 2026.
Mr. Cooper was President-Europe at Bristol Myers Squibb Co. from 2010 to 2015.
Mr. Cooper completed undergraduate education at St. Francis Xavier University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-04-2026 | 10.000 ( 0,01% ) | 18 500 $ | 31-05-2026 | |
| 22-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Ronald Cooper
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Voorzitter | 07-06-2024 |
| ENGENE THERAPEUTICS INC. | Algemeen Directeur | 21-07-2024 |
Eerdere bekende functies van Ronald Cooper
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERATION BIO CO. | Directeur/Bestuurslid | 06-02-2026 |
| ALBIREO PHARMA, INC. | Algemeen Directeur | 02-03-2023 |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Algemeen Directeur | 01-11-2016 |
| GENOCEA BIOSCIENCES, INC. | Directeur/Bestuurslid | 12-04-2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-11-2015 |
Opleiding van Ronald Cooper
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
St. Francis Xavier University
 St. Francis Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
